Colgate-Palmolive director acquires 238 shares via compensation

Colgate-Palmolive Company director reports stock acquisition under compensation plan A director of Colgate-Palmolive Company reported acquiring 238 shares of common stock on 01/02/2026 at a price of $78.66 per share.

Rhea-AI Filing Summary

Colgate-Palmolive Company director reports stock acquisition under compensation plan

A director of Colgate-Palmolive Company reported acquiring 238 shares of common stock on 01/02/2026 at a price of $78.66 per share. The filing notes this represents a portion of the director’s annual cash retainer that was deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors.

Following this transaction, the director beneficially owns 5,313 shares of Colgate-Palmolive common stock directly and 36 shares indirectly through a family trust.

Insider Trade Summary

Grant/Award: 238 shares

Grant/Award 2 txns

Insider Newman Brian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	238	$78.66	$19K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,313 shares (Direct); Common Stock — 36 shares (Indirect, By Family Trust)

Footnotes (1)

1. F1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Colgate-Palmolive (CL) report on January 2, 2026?

A Colgate-Palmolive director reported acquiring 238 shares of common stock on 01/02/2026 at $78.66 per share.

How did the Colgate-Palmolive (CL) director acquire the 238 shares?

The 238 shares were acquired as a portion of the annual cash retainer that was deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

How many Colgate-Palmolive (CL) shares does the director own after this transaction?

After the reported transaction, the director beneficially owns 5,313 shares of Colgate-Palmolive common stock directly and 36 shares indirectly through a family trust.

What is the relationship of the reporting person to Colgate-Palmolive (CL)?

The reporting person is a director of Colgate-Palmolive Company and filed the report as a single reporting person.

Was the Colgate-Palmolive (CL) director’s transaction part of a compensation or investment plan?

Yes. The filing states the acquisition reflects a portion of the annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors.

Does the Form 4 mention indirect ownership for the Colgate-Palmolive (CL) director?

Yes. In addition to directly held shares, the director reports 36 shares of common stock held indirectly through a family trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/06/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newman Brian

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A(1)		238	A	$78.66	5,313	D
Common Stock								36	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.